BeOne Medicines Recognized as "Outstanding Global Oncology Company of the Year" at HKCT Business Awards 2026
HONG KONG SAR - Media OutReach Newswire - 11 May 2026 - BeOne Medicines (BeOne, Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it has been named "Outstanding Global Oncology Company of the Year" at the HKCT Business Awards 2026. The award recognizes BeOne's continued progress in research and development (R&D) and manufacturing of innovative cancer therapies, as...
read full article
